Currently Browsing: News

News

ACRO & TransCelerate Issue a Joint Statement on Considerations while Developing Clinical Study Reports (CSRs)

September 12, 2022

Our member companies have faced widespread clinical trial disruptions in the past few years – from the global pandemic, to the war…

News

OPINION: Keep Our Foot on the Gas for Clinical Trial Diversity

August 8, 2022

The below is an Op-Ed authored by ACRO Chair, Jackie Kent, for MedPage Today on August 6, 2022. Read the full article…

News

ACRO Congressional Update – ADPPA

July 11, 2022

With bipartisan sponsorship from Representatives Pallone (D-NJ) and McMorris Rodgers (R-WA) the American Data Privacy and Protection Act (ADPPA), which would create…

News

ACRO Celebrates 20 Years

April 15, 2022

ACRO Celebrates 20 Years! 20 years ago, contract research organizations were still relatively new players within the clinical research enterprise, and the…

News

OPINION: Clinical Trials in the Spotlight: How to Solidify the Progress Made

November 30, 2021

The below is the Op-Ed authored by ACRO Executive Director, Doug Peddicord for Morning Consult on November 3, 2021. Read the full…

News

ACRO Releases Toolkit to Help Advance Decentralized Clinical Trials

August 11, 2021

Today, ACRO released its DCT Toolkit, which lays out a vision for how decentralized clinical trials can be planned and executed now…

NewsPress Releases

ACRO Members Heed the UK Government’s Call for Volunteers in Response to the COVID-19 Pandemic

May 6, 2020

May 6, 2020 – (Washington, DC) – In an effort to fight the global COVID-19 pandemic, over 150 employees from clinical research…

Read More
News

2020 Officers and New Member Announcement

December 17, 2019

Washington DC – The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of Directors has elected Alistair…

Read More
News

ACRO hosts Congressional Briefing on clinical research advancements

October 24, 2019

On Wednesday, October 23, 2019, ACRO hosted a Congressional Briefing on Capitol Hill. With the help of the Congressional Research & Development…

Read More
NewsReports

A Consistent Approach to Risk Based Quality Management: Collaboration is Key

October 24, 2019

Developing, executing and overseeing clinical trials is a complex process. Yet it is essential to gain reliable evidence from clinical trials to…

Read More
NewsReports

New ACRO Report Quantifies Benefits of RBM for Quality Reviews

October 17, 2019

A new report based on a survey of ACRO members reveals that Risk-Based Monitoring (RBM) makes clinical trial quality review more efficient…

Read More
News

Advancing the Adoption of Risk-Based Monitoring Strategies in Clinical Trials

August 16, 2019

On July 17, 2019, under cooperative agreement with the FDA, the Duke-Margolis Center for Health Policy (Duke Margolis) held a public workshop. The event, titled Improving the Implementation of Risk-Based Monitoring Approaches of Clinical Investigations, aimed to identify opportunities to improve Risk Based Monitoring (RBM) implementation and solicit stakeholder input on the challenges, barriers, and enablers that impact the successful adoption of RBM.

Read More
NewsPress Releases

ACRO offers unique insights on risk-based monitoring of clinical trials, calls for adoption of RBM as a best practice

May 16, 2019

Following meetings with then-Commissioner Scott Gottlieb and senior leadership from the Center for Drug Evaluation and Research on the role of CROs and technology companies in designing and implementing risk-based monitoring (RBM) of clinical trials, ACRO this week submitted extensive comments on recent FDA Guidance.Increasing the use of innovative RBM technologies helps make clinical trials safer, more efficient and higher quality. ACRO’s comments offer unique insights into the recent expansion of RBM implementation and call for further increasing the use of these oversight technologies.

Read More
NewsPress Releases

ACRO expands membership with addition of three digital technology companies

April 15, 2019

The Association of Clinical Research Organizations (ACRO) is pleased to announce the expansion of its membership to include ERT, Oracle and Veeva. These new ACRO member companies, with their focus on digital technologies that enable global clinical trials, characterize the ongoing innovation and evolution of contemporary clinical research. ACRO now has 12 member companies.

Read More
News

ACRO testifies before IRS and Treasury Department on proposed Base Erosion and Anti-Abuse Tax (BEAT) regulation

March 29, 2019

On Monday, March 25, 2019 ACRO provided testimony at a public hearing held by the Internal Revenue Service (IRS) and Treasury Department…

Read More
News

EU efforts turn towards digital for 2019

February 27, 2019

2018 was a busy and productive year for ACRO’s European Scientific & Regulatory Committee, which meets quarterly in London. While the Committee focused largely on the continuing implementation of the EU Clinical Trial Regulation, there were also opportunities to engage with regulators on other topics ranging from European regulatory strategy to Advanced Therapies to the urgent challenges of Brexit.

Read More
NewsPress Releases

Dr. Cynthia Verst of IQVIA Elected 2019 ACRO Chair

January 30, 2019

Washington DC – The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of Directors has elected Dr. Cynthia Verst,…

Clinical Research Roundtable event with Lord O'Shaughnessy, Parliamentary Under-Secretary (Department of Health and Social Care) at Barts Health, London, hosted by IQVIA.
Read More
NewsPress Releases

UK Government focus on strengthening clinical research amidst unique challenges of Brexit

November 28, 2018

The Association of Clinical Research Organizations (ACRO) convenes discussion series that seeks to advance an industry with important health and economic impacts…

Read More
News

ACRO members talk UK competitiveness and enabling post-Brexit success

July 18, 2018

What happens to clinical research when the UK leaves the EU’s common market and regulatory structure? When public perceptions seem locked onto…

Read More
News

Who’s in and who’s out? ACRO talks Inclusion-Exclusion Criteria

May 29, 2018

ACRO joins FDA public meeting to discuss trial risks and rationale, benefits and barriers Clinical trials have an enormous number of inter-related,…